Healthcare
Lenskart Solutions Ltd
LENSKART · NSE · INE956O01016Market Cap—
P/E182.8
P/B13.8
EPS₹3.81
Div Yield—
ROE6.8%
ROCE5.8%
ROE6.8%
1Y Return+55.81%
Avg. Volume10.9M
Price Chart
About
Lenskart Solutions Ltd is a Healthcare company listed on NSE.
Technicals
Free account
Register freeTechnicals
Create a free account to view momentum, moving averages, and delivery signals.
Quant
Premium
UpgradeQuant metrics
Upgrade to view volatility, drawdown, factor, and risk metrics.
Key Ratios
Market Cap—
Current Price—
52W High / Low—
Stock P/E182.8
Price to Book13.8
EPS (TTM)₹3.81
Dividend Yield—
ROE6.8%
1Y Return+55.81%
Day Change—
Profit & Loss
| Period | TTM | FY26 | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 |
|---|---|---|---|---|---|---|---|---|
| Sales | ₹9,634 Cr | ₹8,814 Cr | ₹6,653 Cr | |||||
| Expenses | ₹7,633 Cr | ₹7,060 Cr | ₹5,676 Cr | |||||
| Operating Profit | ₹2,000 Cr | ₹1,754 Cr | ₹977 Cr | |||||
| OPM % | 21.0% | 20.0% | 15.0% | |||||
| Other Income | ₹186 Cr | ₹153 Cr | ₹351 Cr | |||||
| Depreciation | ₹1,116 Cr | ₹1,048 Cr | ₹797 Cr | |||||
| Interest | ₹191 Cr | ₹178 Cr | ₹146 Cr | |||||
| Profit Before Tax | ₹880 Cr | ₹680 Cr | ₹385 Cr | |||||
| Tax | ₹212 Cr | ₹179 Cr | ₹88 Cr | |||||
| Net Profit | ₹668 Cr | ₹501 Cr | ₹297 Cr | |||||
| EPS (₹) | 4.4 | 2.8 | 3.8 | |||||
| Dividend Payout % | — | 0% | 0% |
Financial history locked
Register freeRegister free to see 5 more years.
Quarterly Results
| Quarter | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Sales | ₹2,714 Cr | ₹2,516 Cr | ₹2,308 Cr | ₹2,096 Cr | ||||
| Expenses | ₹2,126 Cr | ₹1,979 Cr | ₹1,845 Cr | ₹1,683 Cr | ||||
| Operating Profit | ₹588 Cr | ₹536 Cr | ₹462 Cr | ₹413 Cr | ||||
| OPM % | 22.0% | 21.0% | 20.0% | 20.0% | ||||
| Depreciation | ₹305 Cr | ₹288 Cr | ₹270 Cr | ₹253 Cr | ||||
| Interest | ₹53 Cr | ₹44 Cr | ₹49 Cr | ₹45 Cr | ||||
| Net Profit | ₹228 Cr | ₹204 Cr | ₹133 Cr | ₹103 Cr | ||||
| EPS (₹) | 1.3 | 1.2 | 0.8 | 1.2 |
Quarterly history locked
Register freeRegister free to see 4 more quarters.
Balance Sheet
| Period | FY26 | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Liabilities | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Equity Capital | ₹347 Cr | ₹154 Cr | ₹15 Cr | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Reserves | ₹8,391 Cr | ₹5,777 Cr | ₹5,467 Cr | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Borrowings | ₹3,097 Cr | ₹2,740 Cr | ₹2,343 Cr | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Other Liabilities | ₹2,410 Cr | ₹1,719 Cr | ₹1,662 Cr | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Total Liabilities | ₹14,245 Cr | ₹10,390 Cr | ₹9,487 Cr | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Assets | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Fixed Assets | ₹7,740 Cr | ₹6,231 Cr | ₹5,501 Cr | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Investments | ₹571 Cr | ₹1,038 Cr | ₹1,003 Cr | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Receivables | — | — | — | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Inventory | — | — | — | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Cash & Equivalents | — | — | — | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Other Assets | ₹5,822 Cr | ₹3,014 Cr | ₹2,912 Cr | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Total Assets | ₹14,245 Cr | ₹10,390 Cr | ₹9,487 Cr | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Balance sheet history locked
Register freeRegister free to see 5 more years.
Cash Flow
| Period | Operating | Investing | Financing | Net Cash Flow |
|---|---|---|---|---|
| FY26 | ₹1,670 Cr | ₹-2,551 Cr | ₹1,201 Cr | ₹319 Cr |
| FY25 | ₹1,231 Cr | ₹-262 Cr | ₹-535 Cr | ₹434 Cr |
| FY24 | ₹487 Cr | ₹163 Cr | ₹-722 Cr | ₹-72 Cr |
| FY23 | ||||
| FY22 | ||||
| FY21 | ||||
| FY20 |
Cash flow history locked
Register freeRegister free to see 5 more years.
Peer Comparison
| Company | M.Cap | P/E | ROE | 1Y Return |
|---|---|---|---|---|
| Dr. Agarwals Health Care Ltd | ₹16,351 Cr | 111.4 | +8.63% | +3.15% |
| Fabtech Technologies Ltd | ₹656 Cr | 13.5 | +12.5% | -21.51% |
| Fischer Medical Ventures Ltd | — | — | +8.59% | -10.66% |
| Inventurus Knowledge Solutions Ltd | ₹29,900 Cr | 39.8 | +31.46% | +7.00% |
| Indegene Ltd | — | — | +14.4% | +14.54% |
Mutual Fund Holdings
Free account
Register freeMutual fund holdings
Create a free account to see institutional ownership snapshots.
Bulk & Block Deals
Free account
Register freeBulk & block deals
Create a free account to view recent institutional deal activity.
Analyst Estimates
Free account
Register freeAnalyst estimates
Create a free account to view analyst estimate summaries.
Latest News
2026-08-27Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011BSE Filing2026-08-17Lenskart Solutions Ltd (NSE:LENSKART) (Q1 2027) Earnings Call Highlights: PAT Surges 182% as ...GuruFocus.com2026-06-03Lenskart Solutions Ltd (NSE:LENSKART) Q4 2026 Earnings Call Highlights: Record Revenue Growth ...GuruFocus.com
Documents & Filings
rupiya.io is for research and education only. Metrics shown are not investment advice. Validate with SEBI-regulated disclosures before acting.